ATE65403T1 - Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit. - Google Patents
Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit.Info
- Publication number
- ATE65403T1 ATE65403T1 AT87100811T AT87100811T ATE65403T1 AT E65403 T1 ATE65403 T1 AT E65403T1 AT 87100811 T AT87100811 T AT 87100811T AT 87100811 T AT87100811 T AT 87100811T AT E65403 T1 ATE65403 T1 AT E65403T1
- Authority
- AT
- Austria
- Prior art keywords
- human
- promoting
- csf
- haematopoietic
- restoration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1028086 | 1986-01-22 | ||
EP87100811A EP0230980B2 (de) | 1986-01-22 | 1987-01-21 | Pharmazeutischer Stoff für die Förderung der Wiederherstellung der hämatopoietischen Fähigkeit |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE65403T1 true ATE65403T1 (de) | 1991-08-15 |
Family
ID=11745897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT87100811T ATE65403T1 (de) | 1986-01-22 | 1987-01-21 | Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0230980B2 (de) |
AT (1) | ATE65403T1 (de) |
CA (1) | CA1297004C (de) |
DE (1) | DE3771509D1 (de) |
ES (1) | ES2039209T5 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5718893A (en) * | 1984-04-15 | 1998-02-17 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
EP0565722A1 (de) * | 1990-12-25 | 1993-10-20 | Kyowa Hakko Kogyo Co., Ltd. | Pharmazeutische zubereitung zur pernasalen verabreichung |
US5536495A (en) * | 1994-04-15 | 1996-07-16 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
WO1998006422A1 (fr) | 1996-08-13 | 1998-02-19 | Fujisawa Pharmaceutical Co., Ltd. | Agents de proliferation des cellules souches hematopoietiques |
DE19860801A1 (de) * | 1998-12-30 | 2000-07-06 | Rhein Biotech Proz & Prod Gmbh | Rekombinanter Wachstumsfaktor mit der biologischen Aktivität eines G-CSF (Granulocyte Colony Stimulating Factor) |
US6831158B2 (en) | 2000-01-10 | 2004-12-14 | Maxygen Holdings Ltd. | G-CSF conjugates |
US6555660B2 (en) | 2000-01-10 | 2003-04-29 | Maxygen Holdings Ltd. | G-CSF conjugates |
US6646110B2 (en) | 2000-01-10 | 2003-11-11 | Maxygen Holdings Ltd. | G-CSF polypeptides and conjugates |
US8435939B2 (en) | 2000-09-05 | 2013-05-07 | Biokine Therapeutics Ltd. | Polypeptide anti-HIV agent containing the same |
AU2002325819B2 (en) | 2001-07-11 | 2008-06-19 | Maxygen, Inc. | G-CSF Conjugates |
EP1463751B1 (de) | 2001-12-21 | 2013-05-22 | Human Genome Sciences, Inc. | Albuminfusionsproteine |
US7423007B2 (en) | 2002-08-27 | 2008-09-09 | Biokine Therapeutics Ltd. | Cxcr4 antagonist and use thereof |
CA2607844C (en) | 2005-06-01 | 2012-07-10 | Maxygen Holdings Ltd. | Pegylated g-csf polypeptides and methods of producing same |
ES2842210T3 (es) | 2006-12-21 | 2021-07-13 | Biokine Therapeutics Ltd | 4F-benzoil-TN14003 para la movilización de células progenitoras hematopoyéticas con vistas al trasplante |
WO2010092571A2 (en) | 2009-02-11 | 2010-08-19 | Yeda Research And Development Co. Ltd. | Short beta-defensin-derived peptides |
KR101719339B1 (ko) | 2009-06-14 | 2017-03-23 | 바이오카인 테라퓨틱스 리미티드 | 혈소판 수준을 증가시키는 펩타이드 요법 |
EP2841084B1 (de) | 2012-04-24 | 2018-05-30 | Biokine Therapeutics Ltd. | Cxcr4 antagonist peptid zur verwendung in der behandlung von lungenkrebs |
DE102014001250C5 (de) | 2014-02-03 | 2021-07-29 | Carl Freudenberg Kg | Fensterwischer |
EP3744340A3 (de) | 2015-07-16 | 2021-03-03 | Biokine Therapeutics Ltd. | Zusammensetzungen und verfahren zur behandlung von krebs |
AU2017222495B2 (en) | 2016-02-23 | 2019-08-08 | Biolinerx Ltd. | Methods of treating acute myeloid leukemia |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61227526A (ja) * | 1984-07-25 | 1986-10-09 | Chugai Pharmaceut Co Ltd | 新規なコロニー刺激因子 |
ATE65798T1 (de) * | 1985-02-08 | 1991-08-15 | Chugai Pharmaceutical Co Ltd | Menschlicher granuloxcyt-koloniestimulierungsfaktor. |
-
1987
- 1987-01-21 EP EP87100811A patent/EP0230980B2/de not_active Expired - Lifetime
- 1987-01-21 AT AT87100811T patent/ATE65403T1/de not_active IP Right Cessation
- 1987-01-21 ES ES87100811T patent/ES2039209T5/es not_active Expired - Lifetime
- 1987-01-21 CA CA000527852A patent/CA1297004C/en not_active Expired - Lifetime
- 1987-01-21 DE DE8787100811T patent/DE3771509D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0230980B1 (de) | 1991-07-24 |
CA1297004C (en) | 1992-03-10 |
DE3771509D1 (de) | 1991-08-29 |
EP0230980A2 (de) | 1987-08-05 |
EP0230980B2 (de) | 1996-03-20 |
ES2039209T3 (es) | 1993-09-16 |
ES2039209T5 (es) | 1996-07-16 |
EP0230980A3 (en) | 1988-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE65403T1 (de) | Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit. | |
DE3683430D1 (de) | Einen menschlichen granulozytkoloniereizfaktor fuer die behandlung von leukopenien enthaltende pharmazeutische zubereitung. | |
DE69333321D1 (de) | Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten. | |
HK15293A (en) | Biologically active fragments of the human antihemophilic factor and method for their preparation and pharmaceutical preparations | |
ATE227587T1 (de) | Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts | |
IL78553A (en) | Therapeutic compositions of phosphonylmethoxyalkyl adenines | |
EP0177910A3 (de) | Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur systemischen Behandlung von verschiedenen Erkrankungen des Menschen in niedriger Dosierung | |
MX9603927A (es) | Metodo para la estimulacion de hematopoyesis con hemoglobina. | |
EP0151989A3 (en) | Means for the treatment of cardiac diseases | |
ATE74272T1 (de) | Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie. | |
WO1989000582A3 (en) | Human granulocyte-macrophage colony stimulating factor and muteins thereof | |
NZ224116A (en) | Compositions of interleukin-2 and fk565; method of stimulation of the immune system and package | |
DE3771584D1 (de) | Zusammensetzungen und anwendung von interleukin-2 und/oder interferon-beta und des tumor-necrosis-faktors fuer eine kombinationstherapie oder zur herstellung von arzneimitteln oder formulierungen. | |
DE3689921D1 (de) | Menschlicher plazentarer angiogenischer Faktor, geeignet für die Reizung der Kapillarsynthese, der Endothelzellprotease, der DNS-Synthese und der Absiedlung. | |
IT8767494A0 (it) | Composizione liquida per il trattamento preventivo e curativo di malattie crittogamiche di tipo oidio e procedimento per la messa in opera di tale composizione | |
EP0158880A3 (en) | Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them | |
ATA269387A (de) | Pharmazeutisches mittel zur förderung und stimulierung des haarwachstums und zur verringerung von haarausfall auf basis von pyrimidinderivaten, sowie verwendung des mittels | |
EP0267684A3 (en) | Human leukocyte interferon composition and skin treatment | |
SI1016414T1 (en) | Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans | |
ATE66375T1 (de) | Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung. | |
DE69330809T2 (de) | Therapeutisches Agens für Neutropenie | |
Seki et al. | Induction of eosinophil chemotactic factor production from human peripheral blood mononuclear cells by solubilized BALL-1, a B cell lymphoma line | |
ATE65404T1 (de) | Zusammensetzungen und anwendung von interleukin-2 und/oder interferon-beta und des tumor-necrosis- faktors fuer eine kombinationstherapie oder zur herstellung von arzneimitteln oder formulierungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |